Vimarsana
Biggest News Aggregation in the World

Athersys Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Athersys Inc Today - Breaking & Trending Today

Stem Cell Therapy Market size is set to grow by USD 11.65 billion from 2023-2027, Increasing prevalence of chronic diseases boost the market, Technavio - Vimarsana News

Stem Cell Therapy Market size is set to grow by USD 11.65 billion from 2023-2027, Increasing prevalence of chronic diseases boost the market, Technavio

/PRNewswire/ -- The global stem cell therapy market size is estimated to grow by USD 11.65 billion from 2023-2027, according to Technavio. The market is...

StockNews.com Initiates Coverage on Athersys (NASDAQ:ATHX) - Vimarsana News

StockNews.com Initiates Coverage on Athersys (NASDAQ:ATHX)

StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Wednesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance Athersys stock opened at $0.00 on Wednesday. The stock has a market capitalization of $302,423.10, a P/E ratio of 0.00 and a beta […]

Athersys (NASDAQ:ATHX) Research Coverage Started at StockNews.com - Vimarsana News

Athersys (NASDAQ:ATHX) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report released on Wednesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance ATHX opened at $0.00 on Wednesday. Athersys has a twelve month low of $0.01 and a twelve month high of $1.99. The firm […]

Source: wkrb13.com
StockNews.com Initiates Coverage on Athersys (NASDAQ:ATHX) - Vimarsana News

StockNews.com Initiates Coverage on Athersys (NASDAQ:ATHX)

StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note released on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance Shares of ATHX opened at $0.00 on Tuesday. The stock has a market capitalization of $246,876.00, a PE ratio of 0.00 and a […]

Source: wkrb13.com
Athersys (NASDAQ:ATHX) Coverage Initiated at StockNews.com - Vimarsana News

Athersys (NASDAQ:ATHX) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued to investors on Tuesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Athersys Stock Performance Shares of ATHX stock opened at $0.00 on Tuesday. The firm has a market cap of $271,563.60, […]